Cargando…
PIK3CA mutation inhibition in hormone receptor-positive breast cancer: time has come
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BMJ Publishing Group
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7437706/ https://www.ncbi.nlm.nih.gov/pubmed/32817061 http://dx.doi.org/10.1136/esmoopen-2020-000890 |
| _version_ | 1783572671637749760 |
|---|---|
| author | De Mattos-Arruda, Leticia |
| author_facet | De Mattos-Arruda, Leticia |
| author_sort | De Mattos-Arruda, Leticia |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7437706 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | BMJ Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-74377062020-08-24 PIK3CA mutation inhibition in hormone receptor-positive breast cancer: time has come De Mattos-Arruda, Leticia ESMO Open Editorial BMJ Publishing Group 2020-08-17 /pmc/articles/PMC7437706/ /pubmed/32817061 http://dx.doi.org/10.1136/esmoopen-2020-000890 Text en © Author (s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. Published by BMJ on behalf of the European Society for Medical Oncology. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, any changes made are indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. |
| spellingShingle | Editorial De Mattos-Arruda, Leticia PIK3CA mutation inhibition in hormone receptor-positive breast cancer: time has come |
| title |
PIK3CA mutation inhibition in hormone receptor-positive breast cancer: time has come |
| title_full |
PIK3CA mutation inhibition in hormone receptor-positive breast cancer: time has come |
| title_fullStr |
PIK3CA mutation inhibition in hormone receptor-positive breast cancer: time has come |
| title_full_unstemmed |
PIK3CA mutation inhibition in hormone receptor-positive breast cancer: time has come |
| title_short |
PIK3CA mutation inhibition in hormone receptor-positive breast cancer: time has come |
| title_sort | pik3ca mutation inhibition in hormone receptor-positive breast cancer: time has come |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7437706/ https://www.ncbi.nlm.nih.gov/pubmed/32817061 http://dx.doi.org/10.1136/esmoopen-2020-000890 |
| work_keys_str_mv | AT demattosarrudaleticia pik3camutationinhibitioninhormonereceptorpositivebreastcancertimehascome |